PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

FDA delay for ph 3 trial approval, page-30

  1. 13 Posts.
    lightbulb Created with Sketch. 3
    If you had been tracking this for a number of years you’d know why justifiably, and through no fault of long term holders who I really hope get the best outcome.

    Thanks for your contributions.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.